Borrelia and Hydroxychloroquine Not strictly CPn but these cystic bacteria were killed effectively by hydroxychloroquine. Since research into cystic forms is so limited this is included
Repeated respiratory Mycoplasma pneumoniae infections in mice: effects of host genetic background This paper demonstrates who it is possible a ubiquitous pathogen might cause different diseases in different hosts
Ketoconazole and fluconazole reduce resistance of H pylori to flagyl Self explanatory important paper.
Induction of immunity in experimental CPn infection This dissertation holds a good overview of hte lifecycle of CPn as well as offering the possibility of vaccination against this pathogen
Cell death and inflammation during infection with the obligate intracellular pathogen, Chlamydia
Closing on Chlamydia and it's intracellular bag of tricksThis is about chlamydia and it's lifecycle intracellular: how it subverts the host systems and avoids detection
Chlamydia pneumoniae Alters Mildly Oxidized Low-Density Lipoprotein-Induced Cell Death in Human Endothelial Cells, Leading to Necrosis Rather Than ApoptosisThis could also be included in the cardiovascular section as it relates to atherosclerosis, yet it has implications beyond.
Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment Proof of persistenct in spite of "adequate" therapy
Interesting Curriculum Vitae page with research articles This researcher is working on vaccine for CPn and mycoplasma. The extensive research links alone make this page valuable. Long and sort of technical with lots of CD4 and t-cell discussion. Photos of intracellular pathogens.
Family Practice article on persistence of CT in women This article is about CT and how peristence has been shown to be key to recurrent infection with CT.
Persistence in Chlamydiaceae Technical but readable essay on the current understanding and research related to perisistence of CPn. The concept of persistence is not well understood nor is it generally accepted...YET!
Cpn directly interferes with HIF 1a in host cells Cpn changes the genesi of the host cell to suit its needs.
Tryptophan depletion as a mechanism of gamma interferon mediated chlamydia persistence Quote:"Analyses of infected cells cultured in medium with incremental levels of exogenous tryptophan indicated that persistent growth was induced by reducing the amount of this essential amino acid. These studies confirmed that nutrient deprivation by IDO-mediated tryptophan catabolism was the mechanism by which IFN-gamma mediates persistent growth of C. trachomatis."
Role of tryptophan supplementation in chlamydia This paper is interesting in contrast to the paper above. This author postulates in Medical Hypotheses that giving tryptophan along with antibiotics may force cryptic bodies back into metabolizing states and thus vulnerable to antibiotics.
Silencing or Permanent activation of CPnInteresting article on these peculiar forms of existence in the body explaining the invisible and chronic nature of CPn.
PersistenceThis article relates peristence to atherosclerosis and describes the lack of response by the immune system to the bacterial presence in the cells.
___________________________________________________________
On CAPii since Sept '05 for MSii, RAii, Asthmaii, sciatica. EDSSii at start 5.5.(early cane) Now 6 (cane full time) Originally on: Doxyi 200, Azith 3x week, Tinii cont. over summer '07, Revamp of protocol in Summer '08 by Stratton due to functional loss; clarithromy

This will keep me busy for
This will keep me busy for the next two weeks. Thanks for the information.
Michele: Wheldon CAP1st May 2006 IBSi, sinusitis, alopeciai, asthmai, peripheral neuropathy. 26th March 2007 continuous Flagyli at 400mg with 5 day pulses at 1200mg every three weeks. Spokesperson for Ella, RRMSi Cap Started 16 March 2006
___________________________________________________________
Michèle (UK) GFAi: Wheldon CAPi 1st May 2006. Daily Doxyi, Azi MWF, metroi pulse.
Marie, You have been very,
The difference between what we do and what we are capable of doing would suffice to solve most of the world’s problems. Mohandas Gandhi
___________________________________________________________
The difference between what we do and what we are capable of doing would suffice to solve most of the world’s problems. Mohandas Gandhi
Med Hypotheses.
Med Hypotheses. 2005;65(2):243-52.
High risk of schizophrenia and other mental disorders associated with chlamydial infectionsi: hypothesis to combine drug treatment and adoptive immunotherapy.
Fellerhoff B, Laumbacher B, Wank R. Institute of Immunology, Ludwig Maximilians-Universitaet Muenchen, Goethestrasse 31, D-80336 Muenchen, Germany.
Many microbial factors have been implicated as pathogenic factors in mental disorders. Occurrence of such microbial factors also in the mentally unaffected population raised skepticism against such findings, although each microbial factor may cause mental problems only in some individuals, depending on the individual's immunogenetic disposition. Skepticism against the role of infection in schizophrenia was also fostered by the low impact of antiinfections treatment on the course of disease progression in schizophrenia. We discovered previously that neurotrophins like neurotrophin3 (NT-3) and brain-derived neurotrophic factor (BDNF), involved in processes of neuroplasticity, are also secreted by immunei cells, but only by subpopulations of immune cells.
Therefore, infection of the immune cell subpopulation, specialized in secreting BDNF, or of another subpopulation, specialized in secreting NT-3, could distort communication of immune cells with the central nervous system (CNSi). Chlamydiaceae could cause disbalancement of immune cell sub-populations and, in some individuals with a vulnerable disposition, symptoms of mental illness.
Based on previous observations of persisting IgAi titers in some patients with mental illness we hypothesize that the intracellulari parasites Chlamydiaceae are main pathogenic factors in schizophrenia. We hypothesize furthermore that antiinfectious treatment has to be accompanied by adoptive immunotherapy because antibioticsi alone will not restore the balance of immune subpopulations. Our hypothesis is supported by examination of patients with schizophrenia and other mental disorders. Using nested PCRi we found a significant prevalence of the intracellulari parasites Chlamydophila psittaci, C. pneumoniae and Chlamydia trachomatis (9/18, 50%), as compared to controls (8/115, 6.97%) (chi(2)=25.86, Fisher's exact p two-tailed=5x10(-5)).
Treatment with in vitro-activated immune cells together with antibiotic modalities showed sustained mental improvements in patients that did not depend on treatment with antipsychotic drugs. Future controlled studies including sham treatment of patients have to be carried out to prove our hypotheses.
Publication Types: Clinical Trial PMID: 15922095 [PubMed - indexed for MEDLINE]
___________________________________________________________
Nelly (France-neuroLyme and ????)
Wow, Nelly. This is an
Wow, Nelly. This is an amazing piece of research. What is "adoptive immunotherapy?" Makes me wonder if there is a treatment we are missing here.
Now, does this study prove we all actually are all crazy here, as the orthodox medical community insists, or the reverse? Maybe both?
CAPi for Cpni 11/04. Dxi: 25yrs CFSi & FMSi. Protocol: 200mg Doxyi, 500mg MWF Azith, Tinii 1000mg/day pulses; Vit D1000 units, Cytotec 100mg, Plaquenil 100mg, Magnascent Iodine 12 drps/day, T4 & T3
___________________________________________________________
CAPi for Cpni 11/04. Dxi: 25yrs CFSi & FMSi. Currently: 250 aithromycin mwf, doxycycline 100mg BIDi, Tinii 1000mg/day pulses; Vit D2000 units, T4 & T3, 12mg Iodoral
Mol Psychiatry. 2007
Mol Psychiatry. 2007 Mar;12(3):264-72. Epub 2006 Nov 14.Related Articles, Links
Associations between Chlamydophila infectionsi, schizophrenia and risk of HLA-A10.
Fellerhoff B, Laumbacher B, Mueller N, Gu S, Wank R. Institute of Immunology, Ludwig-Maximilans University of Munich, Munich, Germany. barbara.fellerhoff@med.uni-muenchen.de
Several microbes have been suspected as pathogenetic factors in schizophrenia. We have previously observed increased frequencies of chlamydial infections and of human lymphocyte antigeni (HLA)-A10 in independent studies of schizophrenia. Our aim here was to analyze frequencies of three types of Chlamydiaceae in schizophrenic patients (n=72), random controls (n=225) and hospital-patient controls (n=36), together with HLA-A genotypes. Patients were diagnosed with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders-IV. Blood samples were collected at the beginning of hospitalization and analyzed with Chlamydiaceae species-specific polymerase chain reaction (PCRi). Control panels consisted of randomly selected volunteers and hospitalized, non-schizophrenic patients. We found chlamydial infection in 40.3% of the schizophrenic patients compared to 6.7% in the controls. The association of schizophrenia with Chlamydiaceae infections was highly significant (P=1.39 x 10(-10), odds ratio (OR)=9.43), especially with Chlamydophila psittaci (P=2.81 x 10(-7), OR=24.39). Schizophrenic carriers of the HLA-A10 genotype were clearly most often infected with Chlamydophila, especially C. psittaci (P=8.03 x 10(-5), OR=50.00).
Chlamydophila infections represent the highest risk factor yet found to be associated with schizophrenia. This risk is even further enhanced in carriers of the HLA-A10 genotype.
Publication Types: Comparative Study Research Support, Non-U.S. Gov't PMID: 17102800 [PubMed - indexed for MEDLINE]
___________________________________________________________
Nelly (France-neuroLyme and ????)
There's a good article by
So, Norman, your answer to
So, Norman, your answer to my question, "Now, does this study prove we all actually are all crazy here, as the orthodox medical community insists, or the reverse? Maybe both?"?
CAPi for Cpni 11/04. Dxi: 25yrs CFSi & FMSi. Protocol: 200mg Doxyi, 500mg MWF Azith, Tinii 1000mg/day pulses; Vit D1000 units, Cytotec 100mg, Plaquenil 100mg, Magnascent Iodine 12 drps/day, T4 & T3
___________________________________________________________
CAPi for Cpni 11/04. Dxi: 25yrs CFSi & FMSi. Currently: 250 aithromycin mwf, doxycycline 100mg BIDi, Tinii 1000mg/day pulses; Vit D2000 units, T4 & T3, 12mg Iodoral
Oh yeah, blame the cats for
Oh yeah, blame the cats for making people crazy.
CAPi for M.S. since 8/2007. Currently: 100 mg Dox. (2 x day), 250 mg Zithi (3 x week). Second pulse metronidazolei 12/2007.
___________________________________________________________
CAPi for M.S. 8/2007 - 3/2009. Twentieth pulse metronidazolei + INHi completed 3/12/2009. Intermittent treatment thereafter until 8/7/2009.
Well, CPni exposure is
Well, CPni exposure is nearly universal and we're actively treating ours, so I would have to say that suggests it would be the orthodox people who are crazy.
CAPi for M.S. since 8/2007. Currently: 100 mg Dox. (2 x day), 250 mg Zithi (3 x week). Second pulse metronidazolei 12/2007.
___________________________________________________________
CAPi for M.S. 8/2007 - 3/2009. Twentieth pulse metronidazolei + INHi completed 3/12/2009. Intermittent treatment thereafter until 8/7/2009.
The article I linked to
In any case, I thought the rest of the world was mad long before I ever heard of Cpni.
Intriguing finds, Nelly! I
Intriguing finds, Nelly! I wonder if Chlamydia leaves the door unlocked, and then anyone can wander in.
Given those results, then this is even wierder --
Why People With Schizophrenia Have Lower Rates Of Cancer: New Clues
Or is that getting too far away from the topic?
Ron
On CAPi for CFSi starting 01/06 (NE Ohio, USA)
Currently: doxyi & zithi -- continuous; metronidazolei -- 5 days on, 7 days off.
Get the research results you paid for: support Open Access
___________________________________________________________
Ron
On CAPi for CFSi starting 01/06 (NE Ohio, USA)
Began rifampin trial 1/14/09
Currently: on intermittent